{
    "Trade/Device Name(s)": [
        "microINR System",
        "microINR Control Level A",
        "microINR Control Level B"
    ],
    "Submitter Information": "iLine Microsystems S.L.",
    "510(k) Number": "K180780",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060978"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS",
        "GGN"
    ],
    "Summary Letter Date": "March 22, 2018",
    "Summary Letter Received Date": "March 26, 2018",
    "Submission Date": "January 18, 2019",
    "Regulation Number(s)": [
        "21 CFR 864.7750",
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Prothrombin time test",
        "Plasma, coagulation control"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "International Normalized Ratio (INR)",
        "Prothrombin time"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Lyophilized human citrated plasma (controls)"
    ],
    "Specimen Container(s)": [
        "Fingerstick collection (for capillary whole blood)"
    ],
    "Instrument(s)/Platform(s)": [
        "microINR Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Microfluidic technology",
        "Machine vision detection"
    ],
    "Methodologies": [
        "Prothrombin time assay"
    ],
    "Submission Type(s)": [
        "System",
        "Control",
        "Chip",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for microINR System and microINR Control Levels A/B for point-of-care prothrombin time (INR) testing using microfluidic and machine vision technology",
    "Indications for Use Summary": "microINR System is intended for professional use to determine INR for monitoring oral warfarin anticoagulation therapy in patients 18 years and older stabilized for at least 6 weeks; microINR Controls are intended for quality control on the microINR Meter with disposable Chips",
    "fda_folder": "Hematology"
}